Apex Pharmaceuticals, Inc.

Form 483 issued April 18, 2019 · South Plainfield, New Jersey

Inspection
Apr 3 – Apr 18, 2019
Investigator
Unnee Ranjan
Observations
6
Pages
3
FEI number
3006719767

In short: On April 18, 2019, FDA issued a Form 483 with 6 observations to Apex Pharmaceuticals, Inc. in South Plainfield, New Jersey (FEI 3006719767) after an inspection that ran Apr 3 – Apr 18, 2019. The investigator was Unnee Ranjan. Most observations concern facilities & equipment and laboratory controls; the most-cited regulation is 21 CFR 211.67 (equipment cleaning and maintenance).

At a glance

5 of 6 observations on this 483 concern facilities & equipment.

Facilities & equipment5
Laboratory controls1

Most cited: 21 CFR 211.67 (5×) · 211.160(b) (1×)

What FDA observed

Preview: the opening words of each observation

Dashed: section inferred by FDA Intel and checked against the regulation text

  1. 01

    Observation 1: scanned text, readable in the full document.

  2. 02

    Observation 2: scanned text, readable in the full document.

  3. 03

    Observation 3: scanned text, readable in the full document.

  4. 04

    Detergent residual studies were not performed for the detergents (b) (4) which are used for the…

2 more observations

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Apex Pharmaceuticals, Inc.?

FDA listed 6 observations on this Form 483, mostly about facilities & equipment and laboratory controls. The most-cited regulation is 21 CFR 211.67 (equipment cleaning and maintenance). The opening words of each observation are shown on this page.

Who inspected Apex Pharmaceuticals, Inc.?

Unnee Ranjan is named on this Form 483, for the inspection of Apr 3 – Apr 18, 2019. Each investigator has a profile showing what they cite most.

When was Apex Pharmaceuticals, Inc. inspected by FDA?

The inspection ran Apr 3 – Apr 18, 2019, and the Form 483 is dated April 18, 2019.

How do I get the full Form 483 for Apex Pharmaceuticals, Inc.?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free